Learn About Pharmacogenomics & Medication Safety
Your genes play a direct role in how your body processes medications. Enzymes encoded by specific genes — called pharmacogenes — metabolize drugs at different rates depending on the genetic variants you carry. This field of study is called pharmacogenomics, and it has real clinical consequences: the same dose of the same drug can work as expected for one person, cause side effects in another, and have no effect at all in a third.
If you have taken a consumer DNA test from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA, your raw data file already contains many of the genetic variants that are relevant to drug metabolism. That raw data can be analyzed against clinical pharmacogenomics guidelines from organizations like CPIC to identify potential drug-gene interactions — without additional testing.
The articles below cover the fundamentals: what pharmacogenomics is, how raw DNA data is transformed into actionable insights, and how to read a pharmacogenomic report. For deeper dives into specific genes and medications, explore our pharmacogene reference pages and medication pages.
You can also preview a sample Medication Safety Report to see what your results would look like, or upload your DNA data to get started.
For side-by-side comparisons of pharmacogenomics testing services, visit our compare section.
To understand who we are and how we approach pharmacogenomic content, see about DecodeMyBio and our editorial policy.
Start here
New to pharmacogenomics? These three guides cover the essentials.
Top Guides
What Does Poor Metabolizer Mean?
Plain-language breakdown of metabolizer status categories and their clinical significance.
How To Upload Your 23andMe Raw Data
Step-by-step guide to downloading and uploading your raw data file.
Pharmacogenomics for Depression
How CYP2D6 and CYP2C19 results affect antidepressant selection.
Best MTHFR Supplements
Evidence review of methylfolate, B12, and other supplements for MTHFR variants.
All Articles
What Is Pharmacogenomics?
An introduction to pharmacogenomics — the study of how your genes affect your response to medications, and why it matters for drug safety.
6 min read · Last updated February 2025
How Pharmacogenomic Testing Works
A step-by-step explanation of how DNA raw data is analyzed to identify drug-gene interactions, from variant extraction to clinical report.
7 min read · Last updated February 2025
Understanding Your Medication Safety Report
A guide to reading and interpreting your DecodeMyBio Medication Safety Report — what each section means and how to discuss it with your doctor.
5 min read · Last updated February 2025
What Can You Do With 23andMe Raw Data? Best Options (2026)
Already downloaded your 23andMe raw data? Learn the most useful things you can do with it — from medication safety reports to trait analysis. Compare options and find out which one is worth your time.
8 min read · Last updated March 2026
How to Upload and Use AncestryDNA or 23andMe Raw Data
Step-by-step guide to downloading your raw DNA data from AncestryDNA, 23andMe, or other services and uploading it for pharmacogenomic analysis.
6 min read · Last updated February 2026
Use Your 23andMe or AncestryDNA Raw Data for Pharmacogenomic Medication Insights
Your existing 23andMe or AncestryDNA raw data contains pharmacogenomic variants — no new test required. Learn which medications may be affected based on CPIC clinical guidelines, how pharmacogenomic testing cost compares across providers, and what to discuss with your clinician.
12 min read · Last updated March 2026
What Does Poor Metabolizer Mean? CYP2D6 & CYP2C19 Explained
Poor metabolizer means reduced or absent enzyme activity in genes like CYP2D6 and CYP2C19 that changes how your body processes medications. Learn what each metabolizer phenotype means, how CPIC activity scores determine your status, and which drugs are affected.
10 min read · Last updated March 2026
Genetic Testing for Antidepressants: What Your DNA Can and Cannot Tell You
How genetic testing for antidepressants works — what CYP2D6 and CYP2C19 results mean for SSRIs and tricyclics, how pharmacogenomics guides medication choices, and what genetic testing cannot predict about depression treatment.
8 min read · Last updated March 2026
CYP2D6 and Antidepressants: Which Drugs Are Affected?
A categorized list of antidepressants metabolized by CYP2D6 — SSRIs, SNRIs, tricyclics, and others — with CPIC guideline context and what your metabolizer status means.
7 min read · Last updated February 2026
CYP2C19 and SSRI Metabolism: Why This Gene Matters for Antidepressants
How CYP2C19 genetic variants affect SSRI antidepressant metabolism — which SSRIs are CYP2C19-dependent, what metabolizer status means for dosing, and CPIC guideline context.
7 min read · Last updated February 2026
Genetic Testing for ADHD Medications: What Your DNA Can and Cannot Tell You
How genetic testing for ADHD medications works — what CYP2D6 results mean for atomoxetine, why stimulants like Adderall and Ritalin don't have pharmacogenomic guidelines, and what genetic testing cannot predict about ADHD treatment.
7 min read · Last updated March 2026
Genetic Testing for Anxiety Medication: What Your DNA Reveals About Treatment
How genetic testing for anxiety medication works — what CYP2D6 and CYP2C19 results mean for SSRIs, SNRIs, and benzodiazepines, and what pharmacogenomics can and cannot tell you about anxiety treatment.
6 min read · Last updated March 2026
How Accurate Is Genetic Testing for Psychiatric Medications? What 23andMe Data Shows
How accurate is genetic testing for psychiatric medications? What 23andMe raw data reveals about antidepressant metabolism — which genes are covered, what pharmacogenomics can and cannot predict, and how consumer DNA data compares to clinical PGx testing.
8 min read · Last updated March 2026
What Is Nutrigenomics?
An introduction to nutrigenomics — how your genes influence nutrient metabolism, which genes matter most, and what a nutrigenomics report can and cannot tell you about your diet.
8 min read · Last updated February 2026
MTHFR C677T: What It Means and What to Do
A practical guide to the MTHFR C677T variant — what it does, how it affects folate metabolism, heterozygous vs homozygous, food-first strategies, and when to talk to your doctor.
8 min read · Last updated February 2026
Polygenic Risk Scores vs Pharmacogenomics: Which One Actually Changes a Prescription?
Polygenic risk scores estimate disease probability from thousands of variants. Pharmacogenomics maps a focused set of genes to specific drug recommendations. Understand the differences in evidence, output, and clinical use.
10 min read · Last updated February 2026
How To Upload 23andMe Raw Data for Pharmacogenomic Analysis (2026 Guide)
Step-by-step guide to downloading your 23andMe or AncestryDNA raw data file and uploading it to DecodeMyBio for pharmacogenomic analysis. Covers file formats, what to expect, and what your report includes.
8 min read · Last updated March 2026
Intermediate Metabolizer: What It Means for Your Medications
Intermediate metabolizer means you have reduced (but not absent) enzyme activity in a pharmacogene like CYP2D6 or CYP2C19. Learn how this affects drug levels, which medications are impacted, and what CPIC guidelines recommend.
5 min read · Last updated March 2026
Ultrarapid Metabolizer: What It Means and Why It Matters
Ultrarapid metabolizer means your body processes certain drugs much faster than normal, often due to extra gene copies. Learn about CYP2D6 ultrarapid metabolism, which medications are affected, and what CPIC guidelines recommend.
5 min read · Last updated March 2026
MTHFR Supplements: What the Evidence Says (2026)
Supplements discussed for MTHFR C677T and A1298C — methylfolate, B12, the folic acid debate — reviewed against published evidence, not marketing claims.
9 min read · Last updated March 2026
MTHFR Supplements to Avoid: What to Watch For
Which supplements and supplement forms are commonly flagged for MTHFR carriers? Folic acid, cyanocobalamin, and other forms reviewed against evidence.
6 min read · Last updated March 2026
DNA Test for Medication: What Pharmacogenomic Testing Actually Tells You
What a DNA test for medication actually involves — clinical PGx panels vs raw data analysis, which genes and conditions are covered, and what the results can and cannot tell your prescriber.
9 min read · Last updated March 2026
MTHFR and Pregnancy: What the Evidence Actually Shows
What research says about MTHFR gene variants during pregnancy — folate metabolism, neural tube defect risk, folic acid vs methylfolate, and what major health bodies recommend.
8 min read · Last updated March 2026
CYP2D6 Poor Metabolizer: Symptoms, Medications, and What It Means
What it means to be a CYP2D6 poor metabolizer — which medications are affected, what symptoms people report, the difference between side effects and non-response, and what doctors can do.
8 min read · Last updated March 2026
GeneSight Cost, Insurance Coverage & Alternatives (2026 Independent Guide)
Independent guide to GeneSight pricing, insurance coverage (Medicare, Medicaid, BCBS, Tricare, UHC), clinical evidence, and lower-cost pharmacogenomic alternatives including Genomind and raw data analysis.
11 min read · Last updated March 2026
Methylation Testing: What It Is, What It Can and Can't Tell You (2026)
A neutral guide to methylation testing — blood biomarkers, genetic variants like MTHFR, and commercial panels. What each type measures, common reasons people test, limitations, and how to discuss results with a clinician.
10 min read · Last updated March 2026